Kinnevik Results Presentation Deck

Intro Net Asset Value (SEK) 54.0bn Key Financial Data SEKM Net Asset Value Net Asset Value per Share, SEK Share Price, SEK Net Cash/ (Debt) MAKING USE OF MARKET CONDITIONS TO ACCRETE OWNERSHIP IN OUR HIGHEST-CONVICTION BUSINESSES SEKM Net Asset Value Net Profit/(Loss) Net Profit /(Loss) per Share Pre Dilution, SEK Net Profit / (Loss) per Share Post Dilution, SEK Change in Fair Value of Financial Assets Dividends Received Dividend Paid Investments Divestments KINNEVIK Interim Report Q2 2023 Change in NAV Q/Q (3)% Q2 2023 -1 410 -5.02 -5.02 Portfolio Overview -1 817 468 -11 2241 -10 30 Jun 2023 54 050 191.93 149.70 8 786 Q2 2022 -6 729 -24.09 -24.09 -9 701 3 077 475 -6 027 31 Mar 2023 55 460 198.02 154.55 10 506 H1 2023 1 136 4.05 4.05 742 468 -11 Change in NAVY/Y (12)% 3 054 -1 030 31 Dec 2022 52 906 188.90 143.50 10 387 H1 2022 -11 270 -40.35 -40.35 -14 290 Sustainability 3 077 2 132 -7 042 30 Jun 2022 61 140 218.32 164.75 13 592 FY 2022 -19 519 -69.83 -69.83 -22 856 3 538 Financial Statements 5 742 -7 043 Other One-Year TSR (9)% Five-Year Annualised TSR +3% "Disciplined capital allocation and using our strong financial position wisely to maximize the impact of our highest-conviction companies are crucial to long-term value creation. During the quarter, our dedication to these priorities and our unique ability to seize oppor- tunities in the current market is manifested by our USD 100m investment in Spring Health. Through this invest- ment, Spring Health represents our largest aggregate investment since we commenced our transformation in 2018. We believe Spring Health also has the poten- tial to become one of the most successful investments in Kinnevik's history." Georgi Ganev CEO of Kinnevik 2

View entire presentation